For the past decade or so, manufacturers of testosterone replacement products have been telling men that a little more testosterone won’t hurt them. Advertising campaigns have created the impression that typical symptoms of aging, including fatigue, muscle loss, and reduced libido, are all signs of…
In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized all federal Xarelto lawsuits into one court in the Eastern District of Louisiana. At the time, about 50 product liability lawsuits were pending in the court. That number has now increased to about…
On March 5, 2015, two parents from California filed a new Zofran lawsuit against drug manufacturers GlaxoSmithKline (GSK). They claim that Zofran is to blame for their son’s birth defects. Their case is pending in the Superior Court for the State of California, County of…
The U.S. Judicial Panel on Multidistrict Litigation (JPML) established the Xarelto MDL on December 12, 2014. Since then, all federal cases have been transferred to the Eastern District of Louisiana for pre-trial proceedings. On May 4, 2015, the court released a case management order addressing…
A new Zofran lawsuit has been filed in Texas. The plaintiff, a resident of Texarkana, Texas, claims that the anti-nausea drug, which she took during her pregnancy, caused serious injuries to her child. She seeks in excess of $75,000 in damages from manufacturer GlaxoSmithKline (GSK).…
For several years now, anticoagulant drugs Pradaxa and Xarelto have been linked with serious bleeding events, some of which have caused hospitalizations and even death. The courts have been busy processing lawsuits filed by injured plaintiffs who claim manufacturers overstated the benefits of these
On April 3, 2015, a Montana couple filed a new Zofran lawsuit against manufacturer GlaxoSmithKline (GSK), claiming the anti-nausea drug caused their daughter to be born with a cleft lip and palate. The case is pending in the U.S. District Court of Montana, Billings Division.…
The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana on December 12, 2014. At the time, 21 cases were transferred from ten districts to Louisiana. Since then, many more have joined the…
On June 6, 2014, all federal testosterone replacement therapy [TRT] lawsuits were consolidated into one court in the Northern District of Illinois. Claims include those made against both the name-brand and generic manufacturers of testosterone replacement drugs. Generic drug defendants have recently
On March 6, 2015, an Oakland, California mom filed a new Zofran lawsuit against manufacturer GlaxoSmithKline, LLC (GSK). The plaintiff claims that because she took the anti-nausea medication during pregnancy, her young son was born with a serious heart defect. She seeks compensation for medical…
In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana. Judge Eldon E. Fallon was appointed to oversee the proceedings. Currently, over 400 cases are pending in the Xarelto MDL,…
At the beginning of April 2015, over 1,300 lawsuits had been filed in the testosterone therapy MDL taking place in the U.S. District Court for the Northern District of Illinois. The plaintiffs are typically men who suffered serious side effects, such as heart attack or…